Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (11294)	2/1/1999 8:56:00 AM
From: David Sirk	Read Replies (1) \| Respond to of 25711

I'm playing just fine thank you! Joe take a moment and THINK. If you would not make stupid posts like" I was going to buy CELN but Sirk the Jirk bought it" I would have no need to post here.

To: Joe Copia who wrote (11294)	2/2/1999 1:27:00 PM
From: BarbaraT	Read Replies (1) \| Respond to of 25711

Joe .. what do you think of APPI. Current news: Advanced Plant Pharmaceuticals, Inc.APPI Announces the Signing ofAgreement with TechWave Inc.ShopNow.com) NEW YORK, Feb. 2 /PRNewswire/ -- Advanced Plant Pharmaceuticals, Inc. (OTC Bulletin Board: APPI) announced today that they have signed an agreement with TechWave Inc., the parent Company of ShopNow.com. Advanced Plant Pharmaceuticals, Inc. in continuation with their internet marketing campaign, has signed an agreement with TechWave Inc., parent Company of ShopNow.com. APPI's current line of all natural, standardized, pharmaceutical grade nutritional supplements will be available for purchase by ShopNow.com visitors via an advertising link on ShopNow.com directly to APPI's web site and secure order form. Initially APPI will make available to all ShopNow.com shoppers their fully standardized, pharmaceutical grade, patented, cholesterol lowering agent "Lo-Chol". Lo-Chol is a combination of six different botanicals and has been shown to not only lower total cholesterol and triglycerides, but also increase HDL (good cholesterol) and balance the proportion of HDL to LDL (bad cholesterol). APPI will also introduce their standardized pharmaceutical grade Garlic and "ACA" the nutritional version of Abavca the Company's most clinically advanced pharmaceutical. ACA is derived exclusively from whole plants and has been shown to overcome many of the debilitating symptoms of HIV patients and CFS (Chronic Fatigue Syndrome) while enhancing the immune system. All APPI products are manufactured using APPI's patent pending 13 step proprietary process which creates the best nutritional supplements known to man. APPI's manufacturing process leaves the chemical formation of the Whole Plant in tact, whereas, manufacturing by extraction methods using alcohol castrates the chemical formation of the plant. The total nutritional supplement market is estimated to be in excess of 23 billion dollars annually in the USA. The CFS and Immune markets are estimated to be in excess of 6 billion dollars annually. The cholesterol market in the USA is estimated to be in excess of 4 billion annually. Chief Operating Officer for APPI Barry Clare sees the signing of the TechWave agreement as an exciting marketing tool for the Company's products and technology. Mr. Clare believes that APPI's visibility on the internet will create inroads for future more conventional sales of Advanced Plant Pharmaceutical products. The company expects to announce further agreements in the near future. APPI is a company that develops innovative plant formulations and technology for clinical application. APPI has met FDA nutritional specifications for the marketing of its Lo-Chol in the USA, and has received the first IND from the FDA for a whole plant pharmaceutical which has potential as an immunomodulater in the treatment of patients infected with HIV, the virus that causes AIDS. APPI's Whole Plant Pharmaceutical Grade Process is trade secret and patent pending. Utilization of the APPI process converts a whole plant into the best standardized pharmaceutical grade product. TechWave Inc. is the leader in connecting buyers and sellers worldwide by providing easy-to-use, cost effective commerce solutions. As an experienced e-Commerce outsourcing and marketing company, TechWave enables businesses and consumers to sell or buy anything, at anytime, worldwide. TechWave develops cutting-edge technology, innovative merchant services, and creative distribution systems to help companies sell products and services online. What makes TechWave the complete e-Commerce outsourcing and marketing company is TechWave's dedication to helping retailers, catalog companies, computer companies, and product manufacturers reach new potential customers. TechWave has developed one of the most extensive sales networks on the Internet today: The ShopNow Network. This vast network is comprised of over 15,000 stores found on ShopNow.com and various Internet sites operating under its clients' Internet address. This press release contains forward-looking statements. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements.